Submissions

The Guild regularly makes submissions on proposals and policies likely to impact community pharmacy.

Guild submission to include pharmacists and pharmacy technicians in the 2024 voluntary bonding scheme New!

Guild submission on the proposal to fund candesartan with hydrochlorothiazide tablets for high blood pressure New!

Guild submission to Pharmac proposal to phase out funding of food thickeners in the community

Guild submission to Pharmac proposal to change the way Pulmonary Arterial Hypertension treatments are funded

Guild submission on the barriers preventing community pharmacy from offering Boostrix

Guild submission on the review of pholcodine-containing medicines

Guild submission re: Covid-19 anitivirals - The role of molnupiravir in New Zealand's funded treatments portfolio

Guild submission: Agenda for the 70th meeting of the Medicines Classification Committee

Guild submission on the inclusion of one behaviour in the new Pharmacist Prescriber Competence Standards

Guild submission on proposal to allow funding of Spacers via prescription and supply of spacer devices by pharmacists

Guild submission re: Expression of Interest – National sector guidance to prevent and manage diabetes-related complications

Guild submission on Pharmac proposal to fund rituximab for lgG4-related disease

Guild submission to Petitions Committee for removing prescription charges for Community Services Card holders

Guild submission on the changes to the Primary Care Model of Care for Covid 19

Guild online submission on Safe Access to Opioids - Engagement document

Guild submission on the smokefree environments regulations

Pharmacy Guild Submission - Therapeutic Products Bill

Pharmacy Guild submission - proposal to fund risdiplam (Evrysdi) for spinal muscular atrophy

Pharmacy Guild objection to the Medicines Classification Committee 69th meeting held on the 25th of October 2022

Guild submission on the possible inclusion of a labelling transition period within the Misuse of Drugs Regulations 1977

Guild submission on Proposed Annual Practising Certificate Fee increase for the 2023/24 Practising Year

Guild submission on Pharmac proposal to amend Pharmaceutical Schedule rules on prescribing and dispensing of Class B controlled drugs

Guild submission on proposed changes for skilled migrant category residence visa

Guild submission to Pharmac proposal to list oral vinorelbine

Guild submission on proposal to widen access to meningococcal B vaccine and secure supply of the shingles vaccine

Guild submission on Competence Standards and Guidance for the Pharmacy Profession in Aotearoa NZ

Guild submission on the Public Consultation on Pharmacist Prescriber Competence Standards and Guidance

Guild submission on the proposal to list adrenaline auto-injectors for emergency treatment of severe anaphylaxis

Guild comments regarding the proposal on the Waste Minimisation Amendment regulations (ban on single use straws)

Guild submission on the agenda of the 69th meeting of the Medicine Classification Committee

Agenda item 6.1a: Methenamine hippurate - proposed up-scheduling change to classification

Agenda item 6.1b: Glecaprevir and Pibrentasvir - proposed change to prescription classification statement

Agenda item 6.1e: National immunisation schedule - proposed change to prescription vaccine classification statements

Agenda item 8.2a: Low dose cannabidiol

Guild submission on Council's public consultation on Accreditation Standards and Guidance for Pharmacy Programmes

Guild submission on Pharmac proposal to fund long acting paliperidone and ibrutinib

The Guild welcomes the proposed three monthly paliperidone dosage form - the Guild did not comment on ibutinib.

Guild submission on proposal to widen access to the PCV13 pneumococcal conjugate vaccine for ummunisation against pneumococcal disease

Guild consultation on the proposals to fund treatments for people with kidney disease, osteoporosis, cancers and hyperparathroidism

Guild submission on Pharmac public consultation on proposed 2022-2023 invitation to tender

Guild consultation on the proposed classification of etizolam under the Misuse of Drugs Act 1975

Pharmacy Guild submission to the Primary Health Dataset Programme

Pharmacy Guild feedback on the DRAFT Competency Standards

Pharmacy Guild submission on the Pharmacy proposal to fund Ramipril

Guild submission on Pharmacy proposal on access criteria for two COVID-19 treatments including persistent SARS-CoV-2 infection

Guild submission on the proposal to fund treatments for people with breast and blood cancers

The Guild supported the funding of the treatments.

Guild submission on Pharmac proposal to widen access to progesterone, antiretrovirals and nitrofurantoin

Guild submission to Pharmac proposal to fund treatment earlier for relapsing remitting multiple sclerosis

Submission on the Agenda of the 68th Medicine Classification Committee

The Guild provided feedback on the proposed reclassification of Nitrofurantoin (supported) and Noloxone. (conditional support)

Proposal to widen eligibility criteria for influenza vaccine

The Guild is supportive of the proposed widened access criteria as this will reduce barriers to accessing funded influenza vaccines for Māori and Pacific people ages 55 to 64 years.

Proposal on the implementation plan for pholcodine reclassification

The Guild provided feedback and suggestions to Medsafe to delay the implementation date of the pholcodine reclassification.

Guild submission on the proposals to widen access to rituximab and zoledronic acid

The Guild supported widened access of Rituximab and Zoledronic acid. Highlighted the funding and stock keeping constraints.

Proposal on access criteria for two COVID-19 treatments

The Guild supported wider access to the two Covid-19 treatments to improve equity and stock availability.

Guild submission on proposal to increase list price and subsidy of influenza vaccine for 2022